CNS Stimulants and Cognitive Enhancers Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for CNS Stimulants and Cognitive Enhancers. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 1: Biochemical etiology of Alzheimer's disease relates to:
- A. Dopamine
- B. Acetylcholine (Correct Answer)
- C. GABA
- D. Serotonin
CNS Stimulants and Cognitive Enhancers Explanation: ***Acetylcholine***
- Alzheimer's disease is significantly associated with a **reduction in cholinergic neuronal activity** in the brain, impacting memory and learning.
- Medications for Alzheimer's disease often aim to **increase acetylcholine levels** or prevent its breakdown (e.g., cholinesterase inhibitors).
*Dopamine*
- **Dopamine deficits** are primarily associated with **Parkinson's disease**, affecting motor control and movement.
- While dopamine may play a minor role, it is **not considered the primary biochemical etiology** of Alzheimer's.
*GABA*
- **GABA (gamma-aminobutyric acid)** is the main inhibitory neurotransmitter in the brain and is often associated with anxiety disorders and epilepsy.
- While GABAergic system changes can occur in Alzheimer's, they are **secondary to the primary cholinergic dysfunction**.
*Serotonin*
- **Serotonin** is widely known for its role in mood, sleep, and appetite regulation, and its imbalances are linked to depression and anxiety.
- While some **serotonergic changes** can be observed in Alzheimer's disease, the primary biochemical deficit is not serotonin.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 2: Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?
- A. Tolterodine (Correct Answer)
- B. Mirabegron
- C. Behavioral therapy/bladder training
- D. Oxybutynin
- E. Trospium
CNS Stimulants and Cognitive Enhancers Explanation: ***Tolterodine***
- **Tolterodine** is a **muscarinic antagonist** that blocks acetylcholine receptors in the bladder, reducing detrusor muscle contractions and overactive bladder symptoms.
- Unlike some other anticholinergics like oxybutynin, it has a **lower propensity to cross the blood-brain barrier** and thus a reduced risk of exacerbating cognitive impairment in patients with dementia.
*Mirabegron*
- **Mirabegron** is a **beta-3 adrenergic agonist** that relaxes the detrusor muscle, increasing bladder capacity.
- While it has a different mechanism of action and is less likely to cause anticholinergic cognitive side effects than older anticholinergics, it can still cause **hypertension** and **tachycardia**, which may be problematic in elderly patients with comorbidities.
*Behavioral therapy/bladder training*
- **Behavioral therapy** and **bladder training** are important first-line treatments for overactive bladder.
- However, for patients with **dementia**, cognitive impairment often makes adherence to and understanding of these complex therapies challenging or impossible without significant caregiver support.
*Oxybutynin*
- **Oxybutynin** is an **anticholinergic drug** that is effective for overactive bladder.
- However, it has a **high affinity for muscarinic receptors** in the brain and readily crosses the blood-brain barrier, significantly increasing the risk of **cognitive impairment, confusion, and delirium** in elderly patients, especially those with pre-existing dementia.
*Trospium*
- **Trospium** is a **quaternary amine anticholinergic** that is hydrophilic and has minimal blood-brain barrier penetration.
- While theoretically safer than oxybutynin in terms of CNS effects, it has **lower bladder selectivity** compared to tolterodine and may cause more peripheral anticholinergic side effects (dry mouth, constipation).
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 3: A 30-year-old male presents with a history of consuming an unknown substance. On examination, the patient has diaphoresis, headache, and features resembling acute coronary spasm. Which of the following clinical features is least likely to be present in this patient?
- A. Hypertension
- B. Tachycardia
- C. Hyperthermia
- D. Bradycardia (Correct Answer)
- E. Mydriasis
CNS Stimulants and Cognitive Enhancers Explanation: ***Bradycardia***
- The presented symptoms of diaphoresis, headache, and coronary spasm are consistent with **stimulant intoxication** (e.g., cocaine, amphetamines).
- Stimulants typically cause **tachycardia** due to sympathetic overactivity, making bradycardia the least likely finding.
*Hypertension*
- **Stimulant intoxication** leads to increased sympathetic activity, causing **vasoconstriction** and elevated blood pressure.
- This is a common and expected finding in cases presenting with coronary spasm due to substance abuse.
*Tachycardia*
- **Sympathetic overstimulation** from an unknown substance, particularly stimulants, directly increases heart rate.
- This symptom closely aligns with the patient's presentation of diaphoresis and coronary spasm.
*Hyperthermia*
- Elevated body temperature is a frequent consequence of **stimulant overdose** due to increased metabolic activity and impaired thermoregulation.
- **Diaphoresis** (sweating) can be a compensatory mechanism for hyperthermia or a direct effect of sympathetic activation.
*Mydriasis*
- **Pupillary dilation** is a characteristic finding in sympathomimetic toxidrome caused by stimulant drugs.
- This occurs due to alpha-adrenergic stimulation of the radial muscle of the iris and is commonly seen with cocaine or amphetamine use.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 4: Which of the following medications in the treatment of Parkinson's disease is an NMDA antagonist?
- A. Amantadine (Correct Answer)
- B. Selegiline
- C. Entacapone
- D. Ropinirole
CNS Stimulants and Cognitive Enhancers Explanation: ***Amantadine***
- **Amantadine** is an **NMDA receptor antagonist**, which contributes to its antiparkinsonian effects by modulating glutamatergic neurotransmission.
- It works by reducing the **excitatory effects of glutamate**, potentially improving motor fluctuations and dyskinesia in Parkinson's disease.
*Selegiline*
- **Selegiline** is a **selective irreversible inhibitor of monoamine oxidase B (MAO-B)**, which prevents the breakdown of dopamine.
- It enhances the availability of dopamine in the brain but does not act as an NMDA antagonist.
*Entacapone*
- **Entacapone** is a **catechol-O-methyltransferase (COMT) inhibitor** that prevents the peripheral breakdown of levodopa.
- This action increases the bioavailability of levodopa to the brain, but it is not an NMDA antagonist.
*Ropinirole*
- **Ropinirole** is a **dopamine agonist** that directly stimulates dopamine receptors in the brain.
- It mimics the effects of dopamine but does not interact with NMDA receptors.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 5: With which of the following receptors does theophylline have an antagonistic interaction?
- A. Histamine receptors
- B. Adenosine receptors (Correct Answer)
- C. Imidazoline receptors
- D. Bradykinin receptors
CNS Stimulants and Cognitive Enhancers Explanation: ***Adenosine receptors***
- **Theophylline** acts as a **non-selective competitive antagonist** at **adenosine receptors** (A1, A2A, and A2B).
- This antagonism contributes to its **bronchodilator effects** by blocking adenosine-induced bronchoconstriction and to its **stimulant effects** by enhancing neurotransmitter release.
*Histamine receptors*
- Theophylline does not primarily interact with **histamine receptors**. Its effects are mediated through different mechanisms.
- While histamine plays a role in allergic reactions and airway smooth muscle contraction, theophylline's direct action is not on these receptors.
*Imidazoline receptors*
- Theophylline does not have a significant antagonistic interaction with **imidazoline receptors**.
- These receptors are primarily involved in blood pressure regulation and sympathetic outflow, and are not a key target for theophylline's therapeutic effects.
*Bradykinin receptors*
- Theophylline does not directly antagonize **bradykinin receptors**.
- Bradykinin is a potent vasodilator and inflammatory mediator, but its receptors are not the primary site of action for theophylline.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 6: Modafinil is used for
- A. Psychogenic erectile dysfunction
- B. Narcolepsy (Correct Answer)
- C. Orthostatic hypotension
- D. OCD
CNS Stimulants and Cognitive Enhancers Explanation: ***Narcolepsy***
- **Modafinil** is a **wakefulness-promoting agent** primarily used to improve wakefulness in patients with excessive daytime sleepiness associated with **narcolepsy**.
- Its mechanism involves increasing levels of **dopamine** and **norepinephrine** in specific brain regions, promoting alertness without significant cardiovascular or euphoric effects.
*Psychogenic erectile dysfunction*
- This condition is typically treated with **phosphodiesterase-5 (PDE5) inhibitors** like sildenafil or tadalafil, which improve blood flow to the penis.
- Modafinil has no established role in the treatment of erectile dysfunction, as it does not directly affect the physiological mechanisms of erection.
*Orthostatic hypotension*
- **Orthostatic hypotension** is managed by increasing blood volume and venoconstriction, often using medications like **fludrocortisone** or **midodrine**.
- While modafinil has some sympathomimetic properties, it is not a first-line or common treatment for orthostatic hypotension.
*OCD*
- **Obsessive-compulsive disorder (OCD)** is primarily treated with **selective serotonin reuptake inhibitors (SSRIs)** and cognitive-behavioral therapy (CBT).
- Modafinil is not indicated for OCD and would not address the underlying pathology of obsessions and compulsions.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 7: A mother reports that her daughter ingested a substance in an unknown dose. The girl presents with hypertension, tachycardia, mydriasis, and hyperthermia. What is the most likely substance?
- A. Heroin
- B. Morphine
- C. Cocaine (Correct Answer)
- D. Chlorpheniramine
- E. Organophosphate
CNS Stimulants and Cognitive Enhancers Explanation: ***Cocaine***
- The presented symptoms of **hypertension, tachycardia, mydriasis, and hyperthermia** are characteristic of a **sympathomimetic toxidrome**, frequently caused by cocaine overdose.
- Cocaine acts as a **norepinephrine-dopamine-serotonin reuptake inhibitor**, leading to excessive stimulation of the central and peripheral nervous systems.
*Heroin*
- Heroin is an **opioid**, and overdose generally presents with **respiratory depression, bradycardia, miosis (pinpoint pupils)**, and hypotension, which are contrary to the patient's symptoms.
- Patients typically exhibit central nervous system **depression**, rather than the hyperactive state seen here.
*Morphine*
- Similar to heroin, morphine is an **opioid** and causes symptoms like **respiratory depression, bradycardia, miosis**, and hypotension.
- These effects are the opposite of the **sympathomimetic** signs observed in the patient.
*Chlorpheniramine*
- Chlorpheniramine is an **antihistamine** with significant **anticholinergic effects**. An overdose might cause **mydriasis and tachycardia**, but not typically severe hypertension or hyperthermia as the primary features.
- Other anticholinergic signs such as **dry mucous membranes, urinary retention, and altered mental status (delirium)** would also be expected.
*Organophosphate*
- Organophosphate poisoning causes a **cholinergic toxidrome** due to **acetylcholinesterase inhibition**, resulting in excessive cholinergic stimulation.
- Classic presentation includes **SLUDGE syndrome** (Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis) along with **miosis (pinpoint pupils), bradycardia, bronchospasm**, and muscle fasciculations.
- These findings are the **opposite** of the sympathomimetic signs seen in this patient.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 8: Stimulant drugs are primarily given to children for the treatment of:
- A. Speech developmental disorder
- B. Conduct disorder
- C. ADHD (Correct Answer)
- D. Pervasive disorder
CNS Stimulants and Cognitive Enhancers Explanation: ***ADHD***
- Stimulant medications like **methylphenidate** and **amphetamine** are first-line treatments for attention-deficit/hyperactivity disorder (ADHD) in children.
- They work by increasing the levels of **dopamine** and **norepinephrine** in the brain, improving focus and reducing impulsivity.
*Speech developmental disorder*
- This disorder primarily involves difficulties with **language production** or comprehension.
- Treatment typically focuses on **speech therapy** and educational interventions, not stimulant medications.
*Conduct disorder*
- This condition involves persistent patterns of **antisocial behavior**, aggression, and violations of rules.
- While therapy is the primary treatment, if there are co-occurring symptoms of ADHD, stimulants might be used to address those specific symptoms, but aren't a direct treatment for conduct disorder itself.
*Pervasive disorder*
- This term is an older term for what is now known as **autism spectrum disorder (ASD)**.
- There is no evidence that stimulant medications are effective for the core symptoms of ASD, and they might exacerbate some behavioral symptoms.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 9: Investigation of choice for leptomeningeal carcinomatosis:
- A. Gd enhanced MRI (Correct Answer)
- B. CT scan
- C. SPECT
- D. PET
CNS Stimulants and Cognitive Enhancers Explanation: ***Gd enhanced MRI***
- **Gadolinium-enhanced MRI** is the investigation of choice for **leptomeningeal carcinomatosis** as it can visualize the subtle nodular or linear enhancement along the leptomeninges, indicating tumor dissemination.
- It offers superior **soft tissue contrast** and spatial resolution compared to CT, enabling detection of small lesions and accurate mapping of disease extent.
*CT scan*
- A **CT scan** has limited sensitivity for detecting leptomeningeal involvement due to poor contrast resolution of soft tissues and the dura/arachnoid spaces.
- It might show hydrocephalus or large tumor deposits, but subtle leptomeningeal enhancement is often missed.
*SPECT*
- **Single photon emission computed tomography (SPECT)** is primarily used for functional imaging and is not the investigation of choice for anatomical visualization of leptomeningeal carcinomatosis.
- Its resolution is too low to detect the fine structural changes associated with leptomeningeal spread.
*PET*
- **Positron emission tomography (PET)**, often combined with CT, identifies metabolically active tumor cells and can detect diffuse metastatic disease.
- While useful for overall cancer staging and identifying primary lesions, it is less effective than gadolinium-enhanced MRI for directly visualizing the morphology and enhancement patterns of leptomeningeal carcinomatosis due to limited spatial resolution in the CSF spaces.
CNS Stimulants and Cognitive Enhancers Indian Medical PG Question 10: After successful resuscitation,when stable spontaneous circulation is achieved, what should be done next?
- A. Assess spontaneous respiratory effort
- B. Assess volume status
- C. Check CNS involvement (Correct Answer)
- D. Measure blood glucose
CNS Stimulants and Cognitive Enhancers Explanation: ***Check CNS involvement***
- Following **Return of Spontaneous Circulation (ROCS)**, the physician should carefully assess the patient's **neurological status** [2]. This is because neurological damage is a common and critical complication after cardiac arrest [3].
- This assessment involves checking **pupillary reflexes**, **GCS scoring**, and other **neurological signs** specifically to determine the extent of brain injury and guide further treatment [3].
*Assess spontaneous respiratory effort*
- While critical, observing respiratory effort in patients who have achieved ROSC is secondary to assessing CNS function, as **respiratory compromise** is often due to **neurological impairment**.
- **Ventilatory support** and airway management are usually continued during the initial post-ROSC period, rather than immediately relying on spontaneous breathing.
*Assess volume status*
- **Volume status** is important to prevent hypovolemia or hypervolemia, which could negatively impact the recovering heart and organs [3].
- However, the immediate priority after ROSC is often the **brain**, as inadequate cerebral perfusion or reperfusion injury can quickly worsen outcomes.
*Measure blood glucose*
- **Hyperglycemia or hypoglycemia** can affect brain recovery and overall patient outcome.
- While important part of comprehensive post-resuscitation care, it takes lower priority than immediate **neurological assessment**, which directly impacts treatment decisions for brain protection [1], [3].
More CNS Stimulants and Cognitive Enhancers Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
